Diabetes & Endocrinology
Type 1 diabetes has been known as an irreversible condition that no one can fully prevent. But now, several breakthrough studies have emerged that show prevention and management for the illness are possible.
Study Suggests Connection Between Ovarian Cancer and Fibrosis, Provides Possible Risk Management Option
A recent study in Ottawa poses a connection between ovarian fibrosis and the risk of developing ovarian cancer, and hints at a drug that may decrease that risk.
Faced with a daunting rise in diabetes and obesity, bariatric surgeons are extending a lifeline to many patients.
A pilot study to evaluate the effects of high-intensity exercise on metabolism suggests it is an effective option for individuals who have Type 2 diabetes.
Yttrium-90 (Y-90) has long been used to treat liver cancer. Researchers are exploring its potential to treat diseases in other sites, but a number of obstacles have made progress halting.
A new transition model benefits teenagers and young adults with Type 1 diabetes who are moving from pediatric to adult care, researchers say.
Research at the University of Southern California has uncovered a link between air pollution and elevated risk of Type 2 diabetes among overweight Latino children.
Physicians and medical researchers face tremendous challenges in the area of pediatrics. Rising rates of obesity and widespread drug use among children can seem like intractable problems. Here are some of the troubling statistics.
A major trial demonstrated the glucose-lowering drug empagliflozin reduces cardiovascular morbidity and mortality in individuals with Type 2 diabetes and existing cardiovascular disease. Clinicians and researchers discuss how it does so and who is most likely to benefit.
The immune systems of mice can “remember” cancer cells and provide extended immunity, according to research involving technology that carries individualized vaccines to treat certain tumors.
University of Michigan researchers filled nanodiscs — tiny...
- 1 of 3
- next ›